| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/07/2008 | CN101173008A Double-function amalgamation protein, preparation method and application thereof |
| 05/07/2008 | CN101173005A Insect antimicrobial peptide Thanatin derivant, producing method and uses of the same |
| 05/07/2008 | CN101173003A Hundred-paced pit viper toxin thrombinogen excitor, coded sequence and uses thereof |
| 05/07/2008 | CN101172997A Oligopeptide or its modified compound/derivant and application thereof |
| 05/07/2008 | CN101172161A Water-soluble polymers decorated G-CSF conjugates |
| 05/07/2008 | CN101172160A Interferon gamma conjugates |
| 05/07/2008 | CN101172158A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 05/07/2008 | CN101172100A Stable isotonic lyophilized protein formulation |
| 05/07/2008 | CN101172099A Stable isotonic lyophilized protein formulation |
| 05/07/2008 | CN101172091A Technique for preparing amalgamation protein skin-protection product containing albuminar and skin cell growth factor, and uses of the same |
| 05/07/2008 | CN100386433C White-browed snake venom blood coagulation enzyme and its extraction method and application |
| 05/07/2008 | CN100386341C Polypeptide of extracellular domain of sodium pump and use in preparation of drugs for adjusting the activity of sodium pump |
| 05/07/2008 | CN100386116C Sustained release of microcrystalline peptide suspensions |
| 05/07/2008 | CN100386113C Injectio of brain protein hydrolysate and its preparing process |
| 05/06/2008 | US7369946 Crystalline polypeptide for use in the treatment of tumor and cardiovascular and respiratory system disorders |
| 05/06/2008 | US7368580 Method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 05/06/2008 | US7368576 Treating breast cancer by dministering a fibroblast activation protein alpha inhibitor is a thiazolidine or a pyrrolidine linked to an amino acid by a peptide bond, e.g., L-threo-isoleucyl pyrrolidine, L-allo-isoleucyl thiazolidine, L-allo-isoleucyl pyrrolydine, L-glutaminyl thiazolidine |
| 05/06/2008 | US7368570 organometallic singlet oxygen photosensitizer, comprising a metal and one or more ligands, wherein at least one of said ligands has a carbon atom that is covalently bonded to the metal. |
| 05/06/2008 | US7368558 PRO357 nucleic acids |
| 05/06/2008 | US7368554 Polynucleotides encoding BSL2v1c2-Ig |
| 05/06/2008 | US7368553 nucleotide sequences comprising cDNA and genomic DNA that code for angiogenesis factors, used for gene therapy |
| 05/06/2008 | US7368551 De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof |
| 05/06/2008 | US7368545 PCA3 messenger RNA species in benign and malignant prostate tissues |
| 05/06/2008 | US7368543 Diagnosis and treatment of hepatic disorders |
| 05/06/2008 | US7368535 CD200 receptors |
| 05/06/2008 | US7368534 Myostatin and mimetics thereof |
| 05/06/2008 | US7368533 Recombinant polynucleotide comprising a nucleotide sequence encoding a polypeptide epitope of amino acid sequence, wherein the epitope specifically binds to anitbodies from subjects diagnosed with endometriosis |
| 05/06/2008 | US7368532 A non-toxic polypeptide containing a binding domain that binds to the neuronal cell and a translocation domain that translocates the therapeutic agent into the neuronal cell; clostridial neurotoxins |
| 05/06/2008 | US7368530 Human intestinal Npt2B |
| 05/06/2008 | US7368529 Protein isolated from plants (Moringa) or recombinant DNA; enzyme inhibitors; prevention and treatment of metabolic, cardiovascular, and inflammatory diseases |
| 05/06/2008 | US7368528 Salt with physiologically tolerated acid; resistant to enzymatic degradation; oral administration |
| 05/06/2008 | US7368452 for complex formation of hepatitis C non-structural protein-3 (NS3) with NS4A; enhancing the proteolytic efficacy at all of the sites; prevent reproduction of hepatitis virus |
| 05/06/2008 | US7368436 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 05/06/2008 | US7368433 Acetyl-Z-Q-arg-trp-NH2 in which z is derived from amino-2-naphthalenecarboxylic acid and Q is derived from p-iodo-(D)phenylalanine; melanocortin-4 receptor agonist activity; treating obesity, hypertension, type II diabetes, or control of appetite |
| 05/06/2008 | US7368432 Polypeptide analgesics from snail venom; analogous to the naturally available peptides, and which preferably include two disulfide bonds |
| 05/06/2008 | US7368431 Polypeptide, the conjugate thereof with doxorubicine and a pharmaceutical composition based thereon |
| 05/06/2008 | US7368430 A cell-permeable nuclear factor-kappa B (NF-KB) inhibitor comprising a peptide fragment of the p65 subunit of NF- KB comprising phosphorylation site(s) and an antennapedia-derived protein transduction domain; inhibit inflammatory stimuli; gene expression inhibitors; apoptosis; anticarcinogenic agents |
| 05/06/2008 | US7368429 Mimetic polypeptide for treatment and prevention of nervous system disorders; human myelin basic protein (h-MBP) |
| 05/06/2008 | US7368427 GLP-1 analogues |
| 05/06/2008 | US7368426 Methods for the therapeutic use of cyclosporine components |
| 05/06/2008 | US7368425 Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis |
| 05/06/2008 | US7368424 peptide antibiotics comprising lysobactin derivatives used for treatment and/or prophylaxis of bacterial infectious diseases; cyclic peptides |
| 05/06/2008 | US7368423 Composition and method for treating chronic allograft rejection |
| 05/06/2008 | US7368422 Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| 05/06/2008 | US7368421 Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis |
| 05/06/2008 | US7368295 Nanoparticles comprising biologically active TNF which is immobilized on the same |
| 05/06/2008 | US7368293 Liver enriched transcription factor |
| 05/06/2008 | US7368275 In vivo incorporation of unnatural amino acids |
| 05/06/2008 | US7368270 Polynucleotide encoding polypeptide having phosphatidylserine-specific activity; lipid metabolism enzymes used in diagnosis, treatment, and prevention of cancer, neurological, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 05/06/2008 | US7368261 Conserved Neisserial antigens |
| 05/06/2008 | US7368260 Antidiabetic agents; lipophilic |
| 05/06/2008 | US7368257 Using b-cell receptors as tool in identifying modulators for prevention and treatment of inflammation, autoimmune, transplant rejection and cancer disorders |
| 05/06/2008 | US7368255 Nucleotide sequences coding transcription factor associated with tumor suppressor activity for use in treatment and prevention of cell proliferative disorders |
| 05/06/2008 | US7368254 Lipid-based systems for targeting diagnostic agents |
| 05/06/2008 | US7368251 MEGSIN protein |
| 05/06/2008 | US7368248 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 05/06/2008 | US7368244 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics |
| 05/06/2008 | US7368236 Methods of producing nucleic acid ligands |
| 05/06/2008 | US7368169 Hydrazide compounds with angiogenic activity |
| 05/06/2008 | US7368127 Contacting at least one surface of a biomedical device formed from a reactive mixture comprising at least one latent reactive component with a coating effective amount of at least one peptide containing coating |
| 05/06/2008 | US7368119 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 05/06/2008 | US7368118 gene expression vector comprising polynucleotides that code polypeptides, used to define epitopes that stimulate human leukocyte antigens, for prophylaxis of viral diseases |
| 05/06/2008 | US7368116 Method of enhancing a targeted immune response against tumors |
| 05/06/2008 | US7368115 Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (PACAP) |
| 05/06/2008 | US7368114 CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin containing a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. |
| 05/06/2008 | US7368113 Hormonally up-regulated, neu-tumor-associated kinase |
| 05/06/2008 | US7368111 Immunoglobulin for use in diagnosis, prevention and treatment of autoimmune, immunological and inflammatory disorders; immunotherapy |
| 05/06/2008 | US7368109 For ameliorating acquired immunodeficiency syndrome (AIDS), an antoimmune disease, or graft rejection |
| 05/06/2008 | US7368108 Glycopeptide remodeling using amidases |
| 05/06/2008 | US7368107 Tumor antigen peptides derived from cyclophilin B |
| 05/06/2008 | US7368106 Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state |
| 05/06/2008 | US7368104 Glycopyrrolate in sustained releae form; antimuscarinic agents |
| 05/06/2008 | CA2322229C Compositions comprising heparin and soluble tnf receptors for inhibition of tnf activity |
| 05/06/2008 | CA2311311C Biodegradable intra vaginal devices |
| 05/06/2008 | CA2283868C Photosensitizer conjugates for pathogen targeting |
| 05/06/2008 | CA1341572C Protective antibodies to serotypic determinants of flagellar antigens |
| 05/02/2008 | WO2008052185A2 Materials and methods for the treatment of celiac disease |
| 05/02/2008 | WO2008052054A2 Synergism between activated immune cells and conventional cancer therapies |
| 05/02/2008 | WO2008052035A1 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
| 05/02/2008 | WO2008051818A2 Spontaneously forming ellipsoidal phospholipid unilamellar vesicles |
| 05/02/2008 | WO2008051689A2 Nitric oxide-blocked cross-linked tetrameric hemoglobin |
| 05/02/2008 | WO2008051505A2 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 05/02/2008 | WO2008051477A2 Hcv ns3 protease inhibitors |
| 05/02/2008 | WO2008051421A2 Peptide-cytotoxic conjugates |
| 05/02/2008 | WO2008051306A1 Soluble tnf receptors and their use in treatment of disease |
| 05/02/2008 | WO2008051247A1 Organ preservation and/or perfusion |
| 05/02/2008 | WO2008051220A1 Interaction of il-27 and il-2 for treatment of tumors |
| 05/02/2008 | WO2008051101A1 Oral submicron particle delivery system for proteins and process for its production |
| 05/02/2008 | WO2008050898A1 PARTIAL FRAGMENT OF REIC/Dkk-3 GENE AND THERAPEUTIC AGENT FOR CANCER CONTAINING THE SAME |
| 05/02/2008 | WO2008050897A1 Metastin derivatives and use thereof |
| 05/02/2008 | WO2008050866A1 Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen |
| 05/02/2008 | WO2008050855A1 Gene sensitive to bone/joint disease and use thereof |
| 05/02/2008 | WO2008050836A1 Agent for ameliorating adverse side-effect of chemotherapeutic agent |
| 05/02/2008 | WO2008050830A1 Anti-hiv agent |
| 05/02/2008 | WO2008050789A1 Use of interleukin-11 as therapeutic agent for heart disease |
| 05/02/2008 | WO2008050754A1 Intracerebral oxidation inhibitor and use thereof |
| 05/02/2008 | WO2008050161A2 Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds |
| 05/02/2008 | WO2008050133A2 Inhibition of beta-amyloid aggregation |
| 05/02/2008 | WO2008049974A2 Peptide vaccine for influenza virus |
| 05/02/2008 | WO2008049942A1 Enzymatic collagen hydrolysate and method for obtaining same |